SPT20 Antibody

What is SPT20 and why is it important to study?

SPT20 is a structural subunit of the SAGA complex that plays a critical role in maintaining the complex's integrity. Originally identified in Saccharomyces cerevisiae as a suppressor of Ty element transposition that affects transcription initiation, SPT20 (also called Ada5 in yeast) serves as a bona fide subunit of the SAGA complex . In humans, SPT20 (hSPT20) is encoded by the SUPT20H gene and functions in autophagy pathways and transcriptional regulation .

The importance of SPT20 stems from its essential role in various cellular processes:

• Maintains structural integrity of the SAGA complex

• Regulates transcriptional activities

• Involved in cellular responses to stress

• Plays a role in development and pathogenesis in fungi like Aspergillus fumigatus

What are the molecular characteristics of SPT20 protein across species?

What are the common research applications for anti-SPT20 antibodies?

Anti-SPT20 antibodies are versatile tools in molecular biology research with several established applications:

• Western Blot: Detecting SPT20 protein expression levels at the expected molecular weight (~100 kDa for human SPT20)

• Immunohistochemistry: Examining SPT20 localization in tissue sections

• Immunoprecipitation (IP): Isolating SPT20-containing complexes for further analysis

• ELISA: Quantitative measurement of SPT20 protein levels

• Chromatin Immunoprecipitation (ChIP): Investigating SPT20 association with specific genomic regions

Each application requires specific optimization depending on the experimental system and antibody characteristics.

How can I validate the specificity of an anti-SPT20 antibody for my research?

Thorough validation is essential before using any anti-SPT20 antibody for research purposes:

• Western blot verification: Confirm detection of a band at the expected molecular mass (~100 kDa for human SPT20, may vary by species)

• Positive and negative controls:

  • Positive: Cell lines/tissues known to express SPT20

  • Negative: SPT20 knockout/knockdown samples or non-expressing tissues

• Immunoprecipitation followed by mass spectrometry: Verify that the antibody pulls down SPT20 and associated SAGA complex components (e.g., TRRAP, GCN5, SGF29, TAF10)

• Cross-reactivity testing: If working across species, test antibody reactivity with SPT20 from different organisms, as domains may be conserved between yeast and mammalian SPT20

• Peptide competition assay: Pre-incubate antibody with the immunizing peptide to confirm signal suppression

What is the optimal protocol for immunoprecipitating SPT20 as part of the SAGA complex?

Based on successful protocols from the literature, an effective immunoprecipitation approach for SPT20-containing SAGA complex requires:

• Cell preparation and lysis:

  • Prepare nuclear extracts from cells of interest (typically 1-2×10⁷ cells)

  • Use a gentle lysis buffer containing 20 mM HEPES pH 7.9, 150 mM NaCl, 0.5% NP-40, and protease inhibitors

• Immunoprecipitation:

  • Pre-clear nuclear extract with protein A/G beads (1 hour at 4°C)

  • Incubate pre-cleared lysate with anti-SPT20 antibodies (4-5 μg) overnight at 4°C

  • Add protein A/G beads and incubate for 2-3 hours

  • Wash extensively with buffer containing reduced detergent concentration

• Verification of complex integrity:

  • Western blot for SAGA complex components (e.g., TRRAP, GCN5, ATXN7, TAF10)

  • Verify absence of TFIID-specific subunits (e.g., TBP, TAF1, TAF4) to confirm specificity

• Enzymatic activity verification:

  • Test histone acetyltransferase (HAT) activity using synthetic H3 peptides

  • Assess deubiquitination (deUb) activity by measuring decrease in monoubiquitinated H2B levels

How can I investigate SPT20's role in transcriptional regulation using antibodies?

To study SPT20's function in transcriptional regulation:

• Chromatin Immunoprecipitation (ChIP):

  • Cross-link protein-DNA complexes using 1% formaldehyde (10 minutes at room temperature)

  • Sonicate chromatin to 200-500bp fragments

  • Immunoprecipitate with anti-SPT20 antibodies

  • Analyze enriched DNA by qPCR or sequencing to identify SPT20-bound genomic regions

  • Focus on promoters of known SAGA-regulated genes

• RNA-seq analysis following SPT20 perturbation:

  • Compare transcriptomes between wildtype and SPT20-depleted cells

  • Identify differentially expressed genes, like the GAG biosynthetic genes (uge3 and agd3) and developmental regulators (medA) identified in A. fumigatus

• Co-immunoprecipitation with transcription factors:

  • Use anti-SPT20 antibodies to pull down SPT20-containing complexes

  • Identify associated transcription factors by Western blot or mass spectrometry

  • Map functional interactions within transcriptional networks

What technical considerations are important when studying different SPT20 isoforms with antibodies?

Human SPT20 has three identified isoforms , requiring careful experimental design to differentiate between them:

How should I address non-specific binding when using anti-SPT20 antibodies?

Non-specific binding is a common challenge with antibodies. For anti-SPT20 antibodies:

• Optimize blocking conditions:

  • Test different blocking agents (BSA, milk, commercial blockers)

  • Increase blocking time (2-3 hours at room temperature or overnight at 4°C)

  • Add 0.1-0.5% Tween-20 to reduce hydrophobic interactions

• Adjust antibody dilution:

  • Titrate antibody concentrations to find optimal signal-to-noise ratio

  • Start with manufacturer's recommended dilution and adjust as needed

• Modify washing protocol:

  • Increase number and duration of washes

  • Use higher salt concentration (up to 500 mM NaCl) in wash buffers

  • Add detergents like Triton X-100 (0.1-0.5%) to reduce background

• Pre-adsorption:

  • Pre-incubate antibody with extracts from cells not expressing SPT20

  • Use species-matched control tissues for pre-adsorption

How can I optimize anti-SPT20 antibodies for studying stress responses in different model organisms?

SPT20 is involved in stress responses, including osmotic stress in C. albicans through the Hog1-MAPK pathway . Optimizing antibody use across model organisms:

• Cross-reactivity assessment:

  • Test antibody recognition of SPT20 in your model organism

  • Sequence alignment between human and target organism SPT20 can predict potential cross-reactivity

  • Consider generating species-specific antibodies if necessary

• Stress response protocols:

  • For osmotic stress: Treat cells with NaCl (0.5-1.5M) or sorbitol (1-2M) for various time points

  • Use phospho-specific antibodies against stress-activated kinases (e.g., Hog1) as positive controls

  • Monitor SPT20 localization, modifications, and complex formation during stress

• Complementation experiments:

  • Utilize the approach described for C. albicans, where CaSPT20 complemented S. cerevisiae spt20Δ/Δ mutant during hyperosmotic stress

  • Use SPT20 antibodies to confirm expression and localization of the complemented protein

• Species-specific assay optimization:

  • Adjust lysis conditions based on cell wall differences between species

  • For fungi, include enzymatic cell wall digestion (e.g., zymolyase for yeast)

  • Modify immunoprecipitation buffers based on species-specific protein interactions

How might anti-SPT20 antibodies be used in studying the relationship between SAGA complex and disease?

The SAGA complex has been implicated in various diseases, and SPT20 antibodies can help investigate these connections:

• Cancer research applications:

  • Immunohistochemistry of tissue microarrays to assess SPT20 expression across tumor types

  • Analysis of SPT20-dependent transcriptional networks in oncogenic pathways

  • Investigation of SPT20's role in regulating genes involved in cell proliferation and survival

• Neurodegenerative disease models:

  • The SAGA complex contains ATXN7, a protein involved in spinocerebellar ataxia

  • Anti-SPT20 antibodies can help investigate how polyQ expansions in ATXN7 affect SAGA complex integrity

  • Co-immunoprecipitation experiments to assess how disease mutations affect SPT20 interactions

• Developmental disorders:

  • Study SPT20's role in regulating developmental genes and pathways

  • Investigate potential interactions with other transcriptional regulators implicated in developmental disorders

What are the considerations for developing engineered antibodies with improved specificity for SPT20?

Based on information about antibody engineering from search result :

• Computational modeling approaches:

  • Use sequence alignment data to identify highly specific epitopes in SPT20

  • Apply computational models to design antibody sequences with customized specificity profiles

  • Balance affinity optimization with specificity requirements

• Phage display optimization:

  • Design selection strategies that include both positive selection (binding to SPT20) and negative selection (not binding to similar proteins)

  • Incorporate multiple rounds of selection with increasing stringency

  • Test variants predicted by computational models

• Cross-specificity vs. high specificity design:

  • For detecting SPT20 across species, design antibodies targeting conserved epitopes

  • For isoform-specific detection, target unique regions

  • Optimize energy functions associated with desired binding profiles

• Validation approaches:

  • Implement rigorous validation using SPT20 knockout controls

  • Compare engineered antibodies with traditional monoclonal and polyclonal options

  • Assess performance across multiple applications (Western blot, IP, IHC)